Evaluation of Neutrophil/Lymphocyte and... (2021 study) Skip to main content
Retrospective Study The journal of international advanced otology 2021

Evaluation of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios in Sudden Sensorineural Hearing Loss and Relationship with Hyperbaric Oxygen Therapy.

Çiçek T, Özbilen Acar G, Özdamar Oİ, The journal of international advanced otology, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked back at records from 60 people with sudden hearing loss and compared blood cell ratios with those of 30 healthy people, then compared patients who did and did not receive hyperbaric oxygen therapy on top of steroid treatment.

What They Found

In this retrospective study of 60 patients with sudden sensorineural hearing loss and 30 healthy controls, neutrophil/lymphocyte and platelet/lymphocyte ratios were significantly higher in patients at diagnosis and fell significantly after treatment (p less than 0.05). The 60 patients were split into two groups of 30 based on whether they received hyperbaric oxygen (HBO) in addition to combined corticosteroid treatment. The HBO group had larger drops in both ratios than the group without HBO, but only the drop in the neutrophil/lymphocyte ratio was statistically significant (p less than 0.05). A higher platelet/lymphocyte ratio was linked to a lower rate of hearing recovery.

What This Means for Canadian Patients

For people with sudden sensorineural hearing loss, this study suggests that blood ratios such as the platelet/lymphocyte ratio may help predict how well hearing recovers. The abstract reports changes in blood ratios in the HBO group, not hearing outcomes by treatment group, so it does not show whether HBO improves hearing. Patients should talk with their ear, nose and throat doctor about their own situation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was retrospective and done at one tertiary center, so it cannot prove that HBO caused the changes in blood ratios, and the abstract does not give details of the HBO protocol such as pressure or number of sessions.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 33893777
Year Published 2021
Journal The journal of international advanced otology
MeSH Terms Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Lymphocytes; Neutrophils; Retrospective Studies; Treatment Outcome

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology